Laxmi Dental Limited Receives BSE and NSE Approvals for ESOP Share Listing
Laxmi Dental Limited has secured in-principle approvals from both NSE and BSE for listing 5.00 lakh equity shares under its Employee Stock Option Scheme 2024. The approvals come with mandatory compliance conditions including regulatory notifications, statutory approvals, and adherence to SEBI regulations before actual listing and trading can commence.

*this image is generated using AI for illustrative purposes only.
Laxmi dental Limited has secured in-principle approvals from both major stock exchanges for listing equity shares under its Employee Stock Option Scheme 2024. The company announced these significant developments through regulatory filings, marking important milestones in its employee benefits program.
Dual Exchange Approvals
The company has now received approvals from both the National Stock Exchange of India Limited (NSE) and BSE Limited for listing up to 5.00 lakh equity shares. The NSE granted approval through letter Ref. No. NSE/LIST/52967 dated April 08, 2026, while BSE issued its approval via letter DCS/ESOP/IP/TS/017/2026-27 dated April 10, 2026.
| Exchange: | Reference Number | Approval Date | Shares Approved |
|---|---|---|---|
| NSE: | NSE/LIST/52967 | April 08, 2026 | 5.00 Lakh |
| BSE: | DCS/ESOP/IP/TS/017/2026-27 | April 10, 2026 | 5.00 Lakh |
| Face Value: | Rs. 2/- each | ||
| Scheme: | Laxmi Dental Employee Stock Option Scheme 2024 |
Listing Conditions and Requirements
Both exchanges have specified mandatory conditions that must be fulfilled before actual listing and trading of shares. The key requirements include:
- Notification to exchanges under Regulation 10(c) after allotment of securities and credit to beneficiaries' accounts
- Receipt of statutory and other approvals from authorities including SEBI, RBI, and MCA
- Compliance with all exchange guidelines, regulations, and directions
- Adherence to SEBI (LODR) Regulations, 2015 conditions
- Compliance with Companies Act provisions and other applicable laws
- Payment of prescribed fees as determined from time to time
Regulatory Compliance Framework
Laxmi Dental Limited has informed both stock exchanges about these developments in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The approvals are granted under the Securities Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
| Compliance Parameter: | Details |
|---|---|
| Regulatory Framework: | SEBI (Share Based Employee Benefits) Regulations, 2021 |
| Disclosure Regulation: | SEBI (LODR) Regulations, 2015 |
| Current BSE Scrip Code: | 544339 |
| Current NSE Symbol: | LAXMIDENTL |
Documentation and Next Steps
Both exchanges have specified comprehensive documentation requirements for final listing approval, including certified copies of statements under SEBI regulations, board resolutions for share allotment, and detailed lists of allottees. The exchanges reserve the right to withdraw approvals if submitted information is found incomplete, incorrect, or misleading.
The company has made the approval letters available on its website at www.laxmidentallimited.com and completed all necessary regulatory disclosures to both exchanges. Trading permissions will be issued by the exchanges upon receipt of notifications under Regulation 10(c) and subject to compliance with stated conditions.
Historical Stock Returns for Laxmi Dental
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.07% | +5.42% | +9.30% | -40.57% | -50.24% | -65.47% |
What percentage of Laxmi Dental's total workforce will be eligible to participate in the Employee Stock Option Scheme 2024?
How might the dilution from 5 lakh new equity shares impact existing shareholders' ownership and the company's earnings per share?
What timeline has Laxmi Dental set for completing the regulatory approvals from SEBI, RBI, and MCA required for actual share listing?


































